SEC Form 4Coverage since May 22, 2026
$JAZZ insider trading
Over the last 12 months, Jazz Pharmaceuticals insiders reported no purchases and 9 sales totaling $8.0M across SEC Form 4 filings. 67% of the activity was filed under pre-arranged 10b5-1 trading plans.
- Bought · 12m
- — 0 events
- Sold · 12m
- $8.0M 9 events
- Events · 12m
- 9 Form 4 filings, grouped
- Insiders · 12m
- 6 distinct reporters
- 10b5-1 share
- 67% pre-arranged plans
Side
Price · $JAZZ · 12Mvia TradingView
Top insiders · 12m
COZADD BRUCE C—3× · $4.4M
Patil Neena MEVP & Chief Legal Officer2× · $561K
Smith Mark Douglas—1× · $267K
McSharry Heather Ann—1× · $482K
Winningham Rick E—1× · $662K
All insider trades
9 events
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Aug 3, 2026 | COZADD BRUCE CD | ▼ Sale | 6,000 | $252.98 | $1.5M | -1.6% | plan |
| Jul 1, 2026 | COZADD BRUCE CD | ▼ Sale | 6,000 | $240.47 | $1.4M | -1.6% | plan |
| Jun 15, 2026 | Smith Mark DouglasD | ▼ Sale | 1,157 | $230.55 | $267K | -10.7% | plan |
| Jun 10, 2026 | Patil Neena MEVP & Chief Legal Officer · O | ▼ Sale | 1,200 | $231.83 | $278K | -2.3% | plan |
| Jun 1, 2026 | COZADD BRUCE CD | ▼ Sale | 6,000 | $235.12 | $1.4M | -1.6% | plan |
| May 28, 2026 | Patil Neena MEVP & Chief Legal Officer · O | ▼ Sale | 1,192 | $236.97 | $282K | -2.2% | plan |
| May 28, 2026 | Pearce SamanthaEVP, Chief Commercial Officer · O | ▼ Sale | 6,907 | $235.41 | $1.6M | -12.1% | — |
| May 22, 2026 | Winningham Rick ED | ▼ Sale | 2,741 | $241.57 | $662K | -22.3% | — |
| May 22, 2026 | McSharry Heather AnnD | ▼ Sale | 2,000 | $241 | $482K | -9.8% | — |
About Form 4
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $JAZZ feed.